Medable
Provides a decentralized clinical trial platform to improve patient enrollment and retention.
What they do
Medable provides a cloud-based platform for decentralized and hybrid clinical trials. The software enables remote consent, electronic clinical outcome assessments, and telemedicine visits, allowing life sciences companies to recruit and retain diverse patient populations globally.
The record
- Vertical
- Clinical Trials
- Sub-segment
- Decentralised trials
- Product type
- Platform software
- Stage
- Series C+
- Headquarters
- Palo Alto, USA
- Region
- North America
- Founded
- 2015
- Total funding
- $504M raised
Notable investors: GSR Ventures, Tiger Global Management, Blackstone Group, Sapphire Ventures.